ANTICANCER ACTIVITY OF PYRIPLATIN, A MONOFUNCTIONAL CATIONIC PLATINUM(II) COMPOUND, IN HUMAN CANCER CELLS

Pyriplatin (cis-diammine(pyridine)chloroplatinum(II) or cDPCP), a platinum-based antitumor drug candidate, is a cationic compound with anticancer properties in mice and is a substrate for the organic cation transporters, hOCT1 and hOCT2, which facilitate oxaliplatin uptake. Unlike cisplatin and oxal...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lovejoy, Katherine S., Serova, Maria, Bieche, Ivan, Emami, Shahin, D'Incalci, Maurizio, Broggini, Massimo, Erba, Eugenio, Gespach, Christian, Cvitkovic, Esteban, Faivre, Sandrine, Raymond, Eric, Lippard, Stephen J.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3170455/
https://ncbi.nlm.nih.gov/pubmed/21750216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-11-0250
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires